Trial Designs for Hematologic Malignancies
Trial Designs for Hematologic Malignancies Designing Effective Clinical Trials for Hematologic Malignancies Introduction to Hematologic Malignancy Trials Hematologic malignancies—including leukemias, lymphomas, and multiple myeloma—present unique challenges in clinical trial design compared to solid tumors. These cancers often have distinct biological behavior, treatment responses, and measurable disease markers. Trials for hematologic cancers must account for factors…